Cabozantinib is a dicarboxylic acid diamide that functions as a multi-tyrosine kinase inhibitor. It is used as a pharmaceutical raw material in the manufacturing of products for oncology research.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 849217-68-1
Cabozantinib S-malate
pharmaceutical raw material
N'1-(4-((6,7-Dimethoxyquinolin-4-yl)oxy)phenyl)-N1-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide hydrochloride
pharmaceutical raw material
Xl-228
pharmaceutical raw material
Repotrectinib
pharmaceutical raw material
Selitrectinib
pharmaceutical raw material
IDRX-42
pharmaceutical raw material
(1,2-dihydroxypropyl)phosphonic acid
pharmaceutical raw material
Phthalylsulfathiazole
pharmaceutical raw material
1-N-[4-(6,7-dimethoxyquinolin-4-yl)oxyphenyl]-1-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
ONIQOQHATWINJY-UHFFFAOYSA-N
COC1=CC2=C(C=CN=C2C=C1OC)OC3=CC=C(C=C3)NC(=O)C4(CC4)C(=O)NC5=CC=C(C=C5)F